The U.S. Supreme Court will once again look at the issue of whether human genes are "patent-eligible" material after it issued a writ of certiorari to a group of plaintiffs involved in a breast cancer-genes patent case. The dispute was filed on behalf of a clinician who wants to examine people for breast cancer genes BRCA1 and BRCA2 without a license from Myriad Genetics, which owns the patents for those genes.
Supreme Court will take another look at human gene patents
SmartBrief Job Listings for Education
|Division Manager, Math & Science||
Johns Hopkins University
|K-12 Teachers Needed at Int’l Schools||
The International Educator
|Instructional Designer, ESL||
Imagine Learning, Inc.
|Sr. Product Manager - Professional Development||
|Sr. Product Manager - Formative Assessment Product Line||